EVEROLIMUS RING-OPENING IMPURITY
UNII H9H8BCZ5QW

Substance Identification & Data

This profile provides standardized clinical and technical data for Everolimus Ring-opening Impurity, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H9H8BCZ5QW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1708118-13-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H9H8BCZ5QW

CAS Registry Number

1708118-13-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EVEROLIMUS RING-OPENING IMPURITY

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C53H83NO14

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IWYZQBWTMLODNQ-CTQWDHTPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

131668358

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(=O)[C@]1(O)O[C@H](C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(COC)=O)C)C)/C)OC)CC[C@H]1C)(=O)N2[C@H](C(O[C@H]([C@@H](C[C@H]3C[C@@H](OC)[C@H](OCCO)CC3)C)CC([C@@H](/C=C(/C=O)\C)C)=O)=O)CCCC2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Everolimus Ring-opening Impurity. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

EVEROLIMUS RETROALDOL DEGRADATION PRODUCT

EVEROLIMUS RING-OPENING IMPURITY

Systematic Nomenclature

(1S,4R,5E)-1-((1R)-2-((1S,3R,4R)-4-(2-HYDROXYETHOXY)-3-METHOXYCYCLOHEXYL)-1-METHYLETHYL)-4,6-DIMETHYL-3,7-DIOXO-5-HEPTEN-1-YL (2S)-1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-DIMETHOXY-3,9,11-TRIMETHYL-12-OXO-3,5,7-TRIDECATRIEN-1-YL)TETRAHYDRO-2-HYDROXY-3-METHYL-2H-PYRAN-2-YL)-2-OXOACETYL)-2-PIPERIDINECARBOXYLATE

SYS

2-PIPERIDINECARBOXYLIC ACID, 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-DIMETHOXY-3,9,11-TRIMETHYL-12-OXO-3,5,7-TRIDECATRIEN-1-YL)TETRAHYDRO-2-HYDROXY-3-METHYL-2H-PYRAN-2-YL)-2-OXOACETYL)-, (1S,4R,5E)-1-((1R)-2-((1S,3R,4R)-4-(2-HYDROXYETHOXY)-3-METHOXYCYCLOHEXYL)-1-METHYLETHYL)-4,6-DIMETHYL-3,7-DIOXO-5-HEPTEN-1-YL ESTER, (2S)-

SYS

2-PIPERIDINECARBOXYLIC ACID, 1-(2-(6-(2,13-DIMETHOXY-3,9,11-TRIMETHYL-12-OXO-3,5,7-TRIDECATRIEN-1-YL)TETRAHYDRO-2-HYDROXY-3-METHYL-2H-PYRAN-2-YL)-2-OXOACETYL)-, 1-(2-(4-(2-HYDROXYETHOXY)-3-METHOXYCYCLOHEXYL)-1-METHYLETHYL)-4,6-DIMETHYL-3,7-DIOXO-5-HEPTEN-1-YL ESTER

SYS

External Clinical & Regulatory Resources

Previous UNIIH9H0T4L03S

Next UNIIH9HCE7993P